Go to deals
Healthcare

Chirana T. Injecta, a.s. has acquired Vitrex Medical A/S

Chirana T. Injecta, a.s. has announced the acquisition of Vitrex Medical A/S, the Danish disposable medical and laboratory devices manufacturing company developing, producing and selling disposable articles, primarily for blood sample taking and analysis. Financial details have not been disclosed.

Chirana T. Injecta, a.s. is a manufacturer of disposable medical devices (lancets, syringes, needles, cannulas).

Oaklins' team in the Czech Republic advised the buyer in this transaction.

Parties

Talk to the deal team

Vladimír Jaros

Principal
Prague, Czech Republic
Oaklins WOOD & Co.

Michal Staron

Associate Partner
Bratislava, Slovakia
Oaklins WOOD & Co.

Related deals

HD Clinical Ltd. has been acquired by NEXUS AG
Healthcare | TMT

HD Clinical Ltd. has been acquired by NEXUS AG

NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.

Learn more
Reed Veterinary Surgery has been acquired by Kin Vet Community
Private Equity | Healthcare

Reed Veterinary Surgery has been acquired by Kin Vet Community

The acquisition of Reed Veterinary Surgery by Kin Vet Community has been successfully completed. Through this acquisition, the surgery joins a community of veterinary clinics where colleagues share knowledge and best practices to improve the wellbeing of their clients and their animals.

Learn more
PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production
Healthcare

PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production

PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.

Learn more